Jeffrey R. Bishop, PharmD, BCPP is an assistant professor of pharmacy and psychiatry at UIC. Dr. Bishop earned his doctor of pharmacy and a master's in clinical investigation at the University of Iowa and went on to complete a fellowship in psychopharmacology and pharmacogenetics there. His research interest is psychiatric pharmacogenetics and his clinical interests include the pharmacotherapy of persons with mood and psychotic disorders.

Research

Dr. Bishop is an investigator in the UIC College of Pharmacy Pharmacogenetics Laboratory and Center for Cognitive Medicine. His area of expertise is investigating pharmacogenetic candidate genes as predictors of response and adverse events in persons treated with psychiatric medications. He is currently involved with studies of the pharmacogenetics of risperidone in first episode schizophrenia patients, the pharmacogenetics of agents used in pediatric bipolar disorder, and the pharmacogenetics of adverse effects of SSRIs in person with depression.

Selected Publications

Bishop JR and Pavuluri MN. Review of Risperidone for the Treatment of Pediatric and Adolescent Bipolar Disorder and Schizophrenia. Neuropsychiatric Disease and Treatment. (In Press).

Bishop JR, Wang K, Moline J, Ellingrod VL. Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet; 2007; 17:358.

Ellingrod VL, Bishop JR, Moline J, Miller D. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull 2007; 40:57-62.

Bishop JR, Ellingrod VL, Moline J, Miller D. Association between G-protein beta subunit (GNB3) polymorphisms and weight gain and clinical response to olanzapine. . Med Sci Monit 2006; 12:47-50.

Schultz SK, Moser DJ, Bishop JR, Ellingrod VL. Phobic Anxiety in Late-Life in Relation to Cognition and 5HTTLPR Polymorphism. Psychiatr Genet 2005; 15:305-306.

Bishop JR, Ellingrod VL, Moline J, Miller D. Association between the polymorphic GRM3 gene and olanzapine response. Schizophr Res 2005; 77:253-260.

Bishop JR and Ellingrod VL. Neuropsychiatric pharmacogenetics: moving towards a comprehensive understanding of predicting risks and response. Pharmacogenomics 2004; 5:463-477.